Cargando…

Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells

BACKGROUND: Application of autologous bone marrow mononuclear cells to “no option” patients with advanced critical limb ischemia (CLI) prevented major limb amputation in 73% patients during the 6-month follow-up. We examined which properties of bone marrow stromal cells also known as bone-marrow der...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altaner, Cestmir, Altanerova, Veronika, Cihova, Marina, Hunakova, Lubica, Kaiserova, Katarina, Klepanec, Andrej, Vulev, Ivan, Madaric, Juraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771988/ https://www.ncbi.nlm.nih.gov/pubmed/24069226 http://dx.doi.org/10.1371/journal.pone.0073722

Ejemplares similares

Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2016)

Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
por: Madaric, Juraj, et al.
Publicado: (2017)

Tumor cell behaviour modulation by mesenchymal stromal cells
por: Kucerova, Lucia, et al.
Publicado: (2010)

Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes
por: Altaner, Cestmir, et al.
Publicado: (2019)

Suicide Gene Therapy Mediated with Exosomes Produced by Mesenchymal Stem/Stromal Cells Stably Transduced with HSV Thymidine Kinase
por: Pastorakova, Andrea, et al.
Publicado: (2020)

TGF-B3 Dependent Modification of Radiosensitivity in Reporter Cells Exposed to Serum From Whole-Body Low Dose-Rate Irradiated Mice
por: Edin, Nina Jeppesen, et al.
Publicado: (2015)

Dental Mesenchymal Stem/Stromal Cells and Their Exosomes
por: Stanko, Peter, et al.
Publicado: (2018)

Low-Dose-Rate Irradiation for 1 Hour Induces Protection Against Lethal Radiation Doses but Does Not Affect Life Span of DBA/2 Mice
por: Edin, Nina Frederike Jeppesen, et al.
Publicado: (2016)

Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia
por: Yanishi, Kenji, et al.
Publicado: (2020)

Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia
por: Scatena, Alessia, et al.
Publicado: (2021)

Gene-Directed Enzyme/Prodrug Therapy of Rat Brain Tumor Mediated by Human Mesenchymal Stem Cell Suicide Gene Extracellular Vesicles In Vitro and In Vivo
por: Tibensky, Miroslav, et al.
Publicado: (2022)

Low-Dose-Rate Radiation-Induced Secretion of TGF-β3 Together with an Activator in Small Extracellular Vesicles Modifies Low-Dose Hyper-Radiosensitivity through ALK1 Binding
por: Hanson, Ingunn, et al.
Publicado: (2022)

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
por: Skóra, Jan, et al.
Publicado: (2014)

Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2020)

Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies
por: Jakubechova, Jana, et al.
Publicado: (2023)

Clinical improvement after autologous bone marrow mononuclear cell transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke
por: Sharma, Alok, et al.
Publicado: (2014)

Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2019)

Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis
por: Ruiz-López, Francisco José, et al.
Publicado: (2016)

Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia
por: Altanerova, U, et al.
Publicado: (2017)

Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results
por: Guo, Jianming, et al.
Publicado: (2018)

Autologous bone marrow-derived mononuclear cell therapy in three patients with severe asthma
por: Aguiar, Fabio S., et al.
Publicado: (2020)

Current Status of Cell-Based Therapy in Patients with Critical Limb Ischemia
por: Jaluvka, Frantisek, et al.
Publicado: (2020)

Autologous bone marrow mononuclear cell transplantation in Duchenne muscular dystrophy – a case report
por: Sharma, Alok, et al.
Publicado: (2014)

Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study
por: Sharma, Alok, et al.
Publicado: (2013)

Efficacy of autologous bone marrow mononuclear cell transplantation in dogs with chronic spinal cord injury
por: Tamura, Katsutoshi, et al.
Publicado: (2020)

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
por: Panunzi, Andrea, et al.
Publicado: (2022)

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
por: Pan, Tianyue, et al.
Publicado: (2019)

Neurobiology of Cancer: The Role of β-Adrenergic Receptor Signaling in Various Tumor Environments
por: Mravec, Boris, et al.
Publicado: (2020)

Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Stem Cells in Subacute Ischemic Stroke Patients
por: Ghali, Azza Abass, et al.
Publicado: (2016)

Efficacy of autologous bone marrow mononuclear cell transplantation therapy in patients with refractory diabetic peripheral neuropathy
por: Mao, Hong, et al.
Publicado: (2019)

Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial
por: Nguyen, Liem Thanh, et al.
Publicado: (2017)

Outcomes of autologous bone marrow mononuclear cell administration in the treatment of neurologic sequelae in children with spina bifida
por: Nguyen, Liem Thanh, et al.
Publicado: (2023)

Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model
por: van Rhijn-Brouwer, Femke Christina Ching-Chuan, et al.
Publicado: (2022)

Evaluation of the autologous bone marrow mononuclear therapy and functional restoration in the scarred myocardium by imaging analysis
por: Gokhale, Alla Gopala Krishna, et al.
Publicado: (2011)

Catheter-based transendocardial delivery of autologous bone marrow-derived mononuclear cells in patients listed for heart transplantation
por: Dohmann, HF, et al.
Publicado: (2003)

Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: A pilot study
por: Prasad, Kameshwar, et al.
Publicado: (2012)

Autologous Bone Marrow Mononuclear Cells in Ischemic Cerebrovascular Accident Paves Way for Neurorestoration: A Case Report
por: Sharma, Alok, et al.
Publicado: (2014)

A Clinical Study of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Patients: A New Frontier
por: Sharma, Alok, et al.
Publicado: (2015)

Effect of IGF-1 and Uncultured Autologous Bone-Marrow-Derived Mononuclear Cells on Repair of Osteochondral Defect in Rabbits
por: Tiwary, Ramesh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8pa04h77433mlrcjr5hbh455n5